相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
Zhaojian Liu et al.
JOURNAL OF PATHOLOGY (2012)
Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells
J. C. Dawson et al.
ONCOGENE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
Nilay Sethi et al.
CANCER CELL (2011)
Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia
Juha Saarikangas et al.
JOURNAL OF CELL SCIENCE (2011)
MTSS1 Overexpression Correlates with Poor Prognosis in Colorectal Cancer
Ding Wang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance
Fei Xie et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
Patryk Moskwa et al.
MOLECULAR CELL (2011)
Efficient in vivo microRNA targeting of liver metastasis
C. Huynh et al.
ONCOGENE (2011)
miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival
Lili Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro
Yihua Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Downregulation of metastasis suppressor 1 (MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer
Ke Liu et al.
BMC CANCER (2010)
Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia
Ester Saus et al.
HUMAN MOLECULAR GENETICS (2010)
Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model
Xin Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway
Amit Gokhale et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)
MicroRNA-183 Family Members Regulate Sensorineural Fates in the Inner Ear
Haiqiong Li et al.
JOURNAL OF NEUROSCIENCE (2010)
The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes
Anna-Barbara Stittrich et al.
NATURE IMMUNOLOGY (2010)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer
Christian Parr et al.
EUROPEAN JOURNAL OF CANCER (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Irene K. Guttilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
Miguel F. Segura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fibroblast migration is mediated by CD44-dependent TGFβ activation
Pinak S. Acharya et al.
JOURNAL OF CELL SCIENCE (2008)
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Margaret S. Ebert et al.
NATURE METHODS (2007)
MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster
Shunbin Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma
Stephanie Ma et al.
HUMAN PATHOLOGY (2007)
Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas
Ying Wang et al.
CANCER INVESTIGATION (2007)
Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients
David G. Hicks et al.
CLINICAL CANCER RESEARCH (2006)
Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field
Ann M. Rajnicek et al.
JOURNAL OF CELL SCIENCE (2006)
Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B
G Bompard et al.
JOURNAL OF CELL SCIENCE (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein
JX Lin et al.
ONCOGENE (2005)
Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4
R Gonzalez-Quevedo et al.
JOURNAL OF CELL BIOLOGY (2005)
A novel actin bundling/filopodium-forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein
A Yamagishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines
S Nixdorf et al.
CANCER LETTERS (2004)
MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription
CA Callahan et al.
GENES & DEVELOPMENT (2004)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase δ
JA Woodings et al.
BIOCHEMICAL JOURNAL (2003)
Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain
PK Mattila et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
MIM, a potential metastasis suppressor gene in bladder cancer
YG Lee et al.
NEOPLASIA (2002)
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells
SJ Santner et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers
LB Strickland et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
